Start-up Australia Ventures

Start-up Australia Ventures is a specialist venture capital firm based in Sydney, Australia, that focuses on the life sciences, biotechnology, and healthcare sectors. Established in 2001, the firm primarily targets seed and early-stage investments to bridge the gap between academic research and commercial success. It is most notably recognized as the founding investor in EvoGenix, an antibody therapeutics company that later merged with Peptech to form Arana Therapeutics. The firm has also played a significant role in the development of other Australian biotech companies, including Bionomics and Telesso Technologies. Start-up Australia Ventures has historically collaborated with government initiatives, such as the Queensland Government's BioStart program, to foster innovation in the region. Its investment portfolio spans various therapeutic areas, including oncology, neurology, and inflammatory diseases, with a focus on modalities like small molecules and monoclonal antibodies.